Last reviewed: 05 Feb 2026 Sources Polyneuropathy After Rapid and Massive Weight Loss, Journal of Clinical Neurology [accessed 18 December 2025] Obesity Treatment, NHS England [accessed 18 December 2025] Effects of weight loss on foot structure and function in obese adults: A pilot randomized controlled trial, Gait & Posture [accessed 18 December 2025] Neurological complications associated with rapid weight loss and nutritional deficiencies following GLP-1 agonist use: a case report, Springer Nature [accessed 18 December 2025] Related weight loss treatments Further reading on weight loss Maintenance hub Liraglutide BMI verification Ozempic for weight loss Semaglutide for weight loss Switching from Saxenda to Mounjaro Is coffee good for weight loss
Wegovy isnt covered in any BCBS CareFirst Exchange plans, but its listed as a tier 2 or tier 4 anti-obesity agent in formularies for large employer-sponsored plans and plans purchased before March 23, 2010
They contain the same active ingredient, in the same doses, and are both injected into your skin once a week
The FDA had logged more than 455 adverse event reports tied to compounded semaglutide and more than 320 tied to compounded tirzepatide as of early 2025
By improving metabolic function, GLP-1RAs may not only enhance disease control but also optimize responses to concomitant therapies during the critical early phases of PsA